- Home
- BLDEW vs CR Comparison
BLDEW vs CR Comparison
Compare BLDEW & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- CR
- Stock Information
- Founded
- BLDEW N/A
- CR 1855
- Country
- BLDEW United States
- CR United States
- Employees
- BLDEW 281
- CR N/A
- Industry
- BLDEW Transportation Services
- CR Metal Fabrications
- Sector
- BLDEW Consumer Discretionary
- CR Industrials
- Exchange
- BLDEW Nasdaq
- CR Nasdaq
- Market Cap
- BLDEW N/A
- CR N/A
- IPO Year
- BLDEW 2019
- CR N/A
- Fundamental
- Price
- BLDEW $0.26
- CR $173.36
- Analyst Decision
- BLDEW
- CR Strong Buy
- Analyst Count
- BLDEW 0
- CR 6
- Target Price
- BLDEW N/A
- CR $166.80
- AVG Volume (30 Days)
- BLDEW N/A
- CR 267.6K
- Earning Date
- BLDEW N/A
- CR 10-28-2024
- Dividend Yield
- BLDEW N/A
- CR 0.47%
- EPS Growth
- BLDEW N/A
- CR N/A
- EPS
- BLDEW N/A
- CR 4.52
- Revenue
- BLDEW N/A
- CR $2,276,600,000.00
- Revenue This Year
- BLDEW N/A
- CR $14.93
- Revenue Next Year
- BLDEW N/A
- CR $6.71
- P/E Ratio
- BLDEW N/A
- CR $38.37
- Revenue Growth
- BLDEW N/A
- CR 11.63
- 52 Week Low
- BLDEW N/A
- CR $102.80
- 52 Week High
- BLDEW N/A
- CR $180.87
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- CR 62.50
- Support Level
- BLDEW N/A
- CR $172.47
- Resistance Level
- BLDEW N/A
- CR $180.87
- Average True Range (ATR)
- BLDEW 0.00
- CR 5.22
- MACD
- BLDEW 0.00
- CR 1.02
- Stochastic Oscillator
- BLDEW 0.00
- CR 76.11
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.